Lingli Xin

Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase

Qi Xiong, Ziwei Huang, Lingli Xin et al. · Cancer Immunology Immunotherapy · 2020 · 70 citations · Full text

Immunohematology, Autoimmune Disease, Anti-pd-1/pd-l1 Antibody +11

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer

Qi Xiong, Boyu Qin, Lingli Xin et al. · Frontiers in Oncology · 2021 · 30 citations · Full text

Proteomics study reveals that the dysregulation of focal adhesion and ribosome contribute to early pregnancy loss

Lingli Xin, Benhong Xu, Li Ma et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2016 · 25 citations · Full text

Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study

Boyu Qin, Lingli Xin, Chen Liang et al. · BMC Cancer · 2024 · 12 citations · Full text

Proteomic study of different culture medium serum volume fractions on RANKL-dependent RAW264.7 cells differentiating into osteoclasts

Qi Xiong, Lihai Zhang, Lingli Xin et al. · Proteome Science · 2015 · 10 citations · Full text